Unilever’s revenue was RMB 238.8 billion yuan in the first half of the year

On July 25,2023,Unilever released its performance report for the first half of 2023.The report showed that Unilever’s revenue was €30.4 billion euros(approximately RMB 238.8 billion yuan) during the period,an increase of 2.7% year-on-year,and its underlying sales increased by 9.1% year-on-year.Among them,the beauty and health business achieved a revenue of €6.2 billion euros (approximately RMB48.6 billion yuan),with the largest growth of 8.6% year-on-year;the personal care business achieved a revenue of €6.9 billion euros(approximately RMB54.1 billion yuan),accounting for 23% of the total revenue.In terms of region,Asia Pacific and Africa are still the largest markets of Unilever,accounting for 44% of its total global revenue,and the sales in China increased by 7.9% year-onyear in the first half of the year.

P&G’s sales revenue was RMB 586.5 billion yuan in the fiscal 2023

On July 28,2023,P&G released its annual report for the fiscal 2023 (from July 2022 to June 2023) and quarterly report for the fourth quarter (from April to June,2023).The reports show that from July 2022 to June 2023,P&G’s sales were $82 billion dollars(approximately RMB586.5 billion yuan),an increase of 2% year-onyear;net profit attributable to the parent company was $14.7 billion dollars (approximately RMB586.5 billion yuan),down slightly from a year earlier.Among them,P&G’s net sales were $20.55 billion dollars(approximately RMB147 billion yuan),an increase of 5% year-onyear;net profit attributable to the parent company was $3.392 billion dollars (approximately RMB24.259 billion yuan),an increase of 11%year-on-year.Compared to previous fiscal years,P&G has reached its peak revenue in nearly 10 years,but the growth has slowed down,and the growth rate of net sales was the lowest in nearly 5 years.It should be noted that P&G began to recover since 2023;especially in April to June this year,P&G ushered in a 5%growth.

Bawei has completed the filing of the first cosmetic raw material

On July 25,2023,the new material No.20230028 named“Pandanus Leaf Extract” has been newly added to the Raw Material Filing Information Platform of the National Medical Products Administration by Guangdong Bawei Biotechnology Corporation,which is the first new cosmetic raw material of Bawei to complete the filing.The raw material is a plant material for the purpose of moisturizing agent,and suitable for rinsing and resident cosmetics,except for sprays.The safe use amount of resident cosmetics is ≤8%,and that of others is ≤30%.

Cosmetics reached the sales of RMB 207.1 billion yuan in the first half of 2023

On July 17,2023,the National Bureau of Statistics released the main data on the total retail sales of social consumer goods in June: In June,the total retail sales of social consumer goods reached RMB3,995.1 billion yuan,an increase of 3.1%year-on-year;among them,the total retail sales of cosmetics above designated size reached RMB45.1 billion yuan,an increase of 4.8% year-on-year,making the highest monthly peak in the first half of the year.In terms of the first half of the year as a whole,the total retail sales of social consumer goods reached RMB22,758.8 billion yuan from January to June,2013,an increase of 8.2% year-on-year.Among them,the total retail sales of cosmetics above designated size reached RMB 207.1 billion yuan,an increase of 8.6% yearon-year,which is outperformed the market on growth rate.

Shanghai Jahwa: Net profit is expected to increase by 81%～100% in the first half of the year

On July 14,2023,Shanghai Jahwa United Co.,Ltd.issued a note on the expected increase in performance for the half year of 2023.Based on the preliminary estimates of its finance department,Shanghai Jahwa is expected to achieve a net profit of RMB285 million yuan to RMB 315 million yuan attributable to the owner of parent company,which will increase RMB128 million yuan to RMB158 million yuan compared to the same period last year,an increase of 81% to 100% year-on-year.For the rise in net profit,Shanghai Jahwa said that it has digested the pressure of overseas business and achieved better operating results through the recovery of domestic business.From performance forecast of the half year,it can be seen that Shanghai Jahwa’s net profit attributable to parent company increased significantly with a good result.

Shanxi Jinbo was listed

On July 20,2023,Shanxi Jinbo Biopharmaceutical Ltd.was listed on Beijing Stock Exchange.As of 10:00 am on the same day,Jinbo’s stock price reached RMB132 yuan/share,an increase of 169% compared to the issue price,with a total market value of RMB 8.888 billion yuan.Jinbo is a representative enterprise in China,which as realized the industrialization of recombinant collagen,especially recombinant humanized collagen.Currently,no enterprise mainly engaged in recombinant collagen business has landed in A-share market,and Jinbo has successfully become the“first stock of A-share recombinant collagen”.In terms of revenue,Jinbo has shown a double-digit growth in the past two years,and even increased by 67% last year to RMB390 million yuan.In the first quarter of 2023,Jinbo’s revenue increased by 98.28% to RMB128 million yuan,and net profit increased by 180.94% to RMB 43 million yuan,hitting a new high in growth rate.

Yunnan Baiyao has completed the filing of the first cosmetic raw material

The new material No.20230026 has been newly added to the Raw Material Filing Information Platform of the National Medical Products Administration by Yunnan Baiyao Group Shanghai Technology Co.,Ltd.The new material is called“PARIS FARGESII Root Extract” in Chinese,which is the first new cosmetic raw material of Yunnan Baiyao to complete the filing.It is reported that the raw material is a plant material,of which species is PARIS FARGESII,aiming to skin protection agent.It can be used for all kinds of cosmetics (expect for spray or aerosol cosmetics).The safe use amount of resident cosmetics is 1.12%,and that of rinsing cosmetics is 2.5%.

Group standard,Stability Test Specification for Cosmetics,was released

On July 18,2023,the group standard,Stability Test Specification for Cosmetics,drafted by several units such as the Key Laboratory of Cosmetic Safety Evaluation of the National Medical Products Administration,Guangdong Youzhi Testing Technology Co.,Ltd.and Zhongshan Tiantu Fine Chemical Co.,Ltd.,was officially released,which will be implemented from July 20,2023.This document implements the concept of risk management,and guides cosmetic research and development institutions and manufacturers to standardize the operation of cosmetic stability test by formulating the standard of cosmetic stability test according to the relevant requirements of health product stability test at home and abroad,so as to provide a basis for the research and development of cosmetics new raw materials or products,safety risk assessment,and product stability inspection after marketing,thus strengthening the supervision of cosmetics,ensuring the safety and effectiveness of products,and promoting the high-quality development of the industry.

Voolga was listed

On August 1,2023,Harbin Voolga Science and Technology Co.,Ltd.held a “cloud ringing bell” ceremony,officially listed on the GEM board of the Shenzhen Stock Exchange,stock code“301371”.As of 9:30 a.m.on the same day,Voolga share price of 80 yuan/ share,43.68% higher than the issue price,the total market value of 32.01 billion yuan.According to the prospectus disclosure,2020-2022,Voolga revenue were 1.585 billion yuan,1.650 billion yuan and 1.769 billion yuan.Among them,the revenue of medicaldevice products will be 880 million yuan,927 million yuan and 865 million yuan,and the revenue of cosmetic products will be 704 million yuan,721 million yuan and 903 million yuan.By 2022,the sales revenue of functional skin care products in the cosmetic category has accounted for 51.05%.In 2021,Voolga ranked first in the market with a market share of 17.5%among medical device stick-on dressings.From the performance point of view,Voolga has been among the first echelon of national beauty listed enterprises.